Neuronostics has developed a clinical decision support system to facilitate clinicians with faster and more accurate diagnosis and prognosis of epilepsy. Currently, the diagnosis of epilepsy requires long-term EEG monitoring, which is expensive, inconvenient, and time-consuming, and prolongs treatment for patients. Neuronostics’ seizure susceptibility assessment technology innovatively uses computer simulations to transform short pieces of EEG information into a mathematical model of the brain, providing rapid and objective insights.